Rational Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,705
| Closed | -$216K | – | 191 |
|
|
2024
Q2 | $216K | Buy |
+7,705
| New | +$212K | 0.02% | 110 |
|
|
2023
Q4 | – | Sell |
-460
| Closed | -$16.9K | – | 259 |
|
|
2023
Q3 | $16.9K | Hold |
460
| – | – | ﹤0.01% | 211 |
|
|
2023
Q2 | $16.9K | Hold |
460
| – | – | ﹤0.01% | 201 |
|
|
2023
Q1 | $18.8K | Hold |
460
| – | – | ﹤0.01% | 197 |
|
|
2022
Q4 | $23.6K | Hold |
460
| – | – | ﹤0.01% | 166 |
|
|
2022
Q3 | $20K | Buy |
460
+1
| +0.2% | +$49 | ﹤0.01% | 167 |
|
|
2022
Q2 | $24K | Buy |
459
+11
| +2% | +$561 | ﹤0.01% | 167 |
|
|
2022
Q1 | $23K | Sell |
448
-17,188
| -97% | -$892K | ﹤0.01% | 177 |
|
|
2021
Q4 | $1.04M | Buy |
+17,636
| New | +$874K | 0.06% | 91 |
|
|
2021
Q1 | – | Sell |
-69,455
| Closed | -$2.56M | – | 218 |
|
|
2020
Q4 | $2.56M | Buy |
69,455
+25,572
| +58% | +$938K | 0.69% | 28 |
|
|
2020
Q3 | $1.53M | Sell |
43,883
-101
| -0.2% | -$3.54K | 0.65% | 46 |
|
|
2020
Q2 | $1.36M | Buy |
+43,984
| New | +$1.49M | 0.71% | 41 |
|
|
2020
Q1 | – | Sell |
-4,164
| Closed | -$155K | – | 422 |
|
|
2019
Q4 | $155K | Sell |
4,164
-6,160
| -60% | -$219K | 0.07% | 225 |
|
|
2019
Q3 | $352K | Buy |
10,324
+5,341
| +107% | +$194K | 0.14% | 179 |
|
|
2019
Q2 | $205K | Sell |
4,983
-6,525
| -57% | -$259K | 0.07% | 214 |
|
|
2019
Q1 | $463K | Sell |
11,508
-43,104
| -79% | -$1.73M | 0.13% | 147 |
|
|
2018
Q4 | $2.26M | Buy |
54,612
+42,834
| +364% | +$1.78M | 0.71% | 38 |
|
|
2018
Q3 | $492K | Buy |
11,778
+4,604
| +64% | +$177K | 0.12% | 155 |
|
|
2018
Q2 | $246K | Sell |
7,174
-15,455
| -68% | -$528K | 0.12% | 174 |
|
|
2018
Q1 | $762K | Buy |
22,629
+3,125
| +16% | +$107K | 0.36% | 105 |
|
|
2017
Q4 | $670K | Buy |
+19,504
| New | +$665K | 0.35% | 118 |
|
|
2017
Q2 | – | Sell |
-24,031
| Closed | -$780K | – | 337 |
|
|
2017
Q1 | $780K | Buy |
24,031
+14,474
| +151% | +$456K | 0.51% | 70 |
|
|
2016
Q4 | $304K | Buy |
+9,557
| New | +$292K | 0.29% | 73 |
|
|
2015
Q3 | $3.28M | Sell |
110,066
-17,128
| -13% | -$549K | 1.33% | 9 |
|
|
2015
Q2 | $4.05M | Hold |
127,194
| – | – | 1.3% | 14 |
|
|
2015
Q1 | $4.2M | Sell |
127,194
-7,447
| -6% | -$237K | 1.02% | 27 |
|
|
2014
Q4 | $3.98M | Buy |
+134,641
| New | +$3.86M | 0.79% | 35 |
|
|
2013
Q4 | $7.67M | Sell |
264,093
-56,868
| -18% | -$1.66M | 0.66% | 23 |
|
|
2013
Q3 | $8.75M | Buy |
320,961
+146,385
| +84% | +$3.98M | 0.67% | 14 |
|
|
2013
Q2 | $4.64M | Buy |
+174,576
| New | +$4.82M | 0.39% | 71 |
|
Other funds holding PFE
Rational Advisors's PFE Position: Q3 2024 in Review
Rational Advisors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,705 shares — an estimated $216K sold.
Rational Advisors first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $8.75M in Q3 2013. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Rational Advisors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- Rational Advisors sold 7,705 Pfizer shares in Q3 2024, an estimated $216K.
- Rational Advisors first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
- Rational Advisors's Pfizer position peaked at $8.75M in Q3 2013.
- 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Rational Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.